• Wednesday, October 16, 2024

News

4.8
Arm Seeks Nvidia as Key Investor for IPO
News

Arm Seeks Nvidia as Key Investor for IPO

U.K.-based chip designer Arm is looking to have Nvidia as a cornerstone investor for its highly anticipated IPO. The two companies have already establ...

4.5
DraftKings Sees Surging Momentum
News

DraftKings Sees Surging Momentum

DraftKings stock rises nearly 7% after an upgrade, signaling a shift in margins and profitability. Cost leverage and potential market-share gains expe...

4.9
Coya Therapeutics Sees Promising Results in Alzheimer's Treatment Study
News

Coya Therapeutics Sees Promising Results in Alzheimer's Treatment Study

Coya Therapeutics announces positive findings in an Alzheimer's treatment study using ld IL-2. Promising results, safety, and tolerability were observ...

4.6
Verizon Shares Slide Amid Legacy Cables Concerns
News

Verizon Shares Slide Amid Legacy Cables Concerns

Verizon shares plummet as concerns grow over legacy lead-sheathed telecom cables, impacting stock performance and raising uncertainties for the future...

4.4
Darktrace Raises Margin Guidance for Fiscal 2023 and Expects Stability in Fiscal 2024
News

Darktrace Raises Margin Guidance for Fiscal 2023 and Expects Stability in Fiscal 2024

Darktrace announces improved margin guidance for fiscal 2023 and expects stability in fiscal 2024, with solid revenue growth and increased annual recu...

4.9
The Impact of Higher Long-Term Interest Rates on the Stock Market
News

The Impact of Higher Long-Term Interest Rates on the Stock Market

Explore the relationship between higher long-term interest rates, corporate earnings, and the stock market's performance. Will earnings growth continu...

4.9
Lyft CEO Buys Large Block of Stock, Showing Confidence in the Company
News

Lyft CEO Buys Large Block of Stock, Showing Confidence in the Company

Lyft CEO David Risher buys a significant number of Lyft stocks, expressing optimism for the company's future.

4.4
Welireg Shows Positive Results in Late-Stage Study
News

Welireg Shows Positive Results in Late-Stage Study

Merck's cancer drug Welireg shows promising results in a late-stage study for renal cell carcinoma treatment. Improvement in progression-free survival...

4.7
The Impact of China's Economic Slowdown on the U.S. Tech Sector
News

The Impact of China's Economic Slowdown on the U.S. Tech Sector

An economic slowdown in China has raised concerns about its potential impact on the U.S. tech sector, particularly for companies heavily relying on re...

4.4
Strong Back-to-School Start Boosts The Children's Place Shares
News

Strong Back-to-School Start Boosts The Children's Place Shares

The Children's Place reports strong start to back-to-school season with better-than-expected sales, despite challenges. Optimistic about future perfor...